|Bid||31.44 x 1100|
|Ask||37.72 x 1000|
|Day's range||31.45 - 31.95|
|52-week range||24.97 - 44.42|
|Beta (5Y monthly)||0.85|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Zealand Pharma AS (ZEAL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
A new, easier-to-administer treatment for severe hypoglycemia has observers and investors wondering where its creators will go next.
ZEAL earnings call for the period ending September 30, 2020.